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organism which has a short life cycle, can 
be easily  cultivated, and is small enough to 
be handled in large numbers, like a micro-
organism. It should have relatively few cells, 
so that exhaustive studies of lineage and 
patterns can be made, and should be ame-
nable to genetic analysis.”
Accordingly, Dr. Brenner introduced 
Caenorhabditis briggsae (a close relative of 
C. elegans) – a non-parasitic nematode – as a 
model organism to study complex biological 
regulations at the molecular level. Seminal 
discoveries made using C. elegans as a model 
include cell fate mapping, the genetics of 
basic nervous system development, cell fate 
determination, programed death (apopto-
sis), RNA interference, and more. C. elegans 
has served biology extremely well during the 
last 50 years as reflected in six Nobel Prizes 
using the model – one of which Dr. Brenner 
shared with Drs. Horvitz and Sulston in 
Physiology or Medicine for their discover-
ies about the genetic regulation of organ 
development and programed cell death (1).
In his lecture at USU, Dr. Brenner argued 
that biology has reached another inflection 
point: rodent models may be close to the 
end of their usefulness as far as human 
disease modeling is concerned. Our under-
standing of basic biological processes has 
grown immensely thanks to studies utiliz-
ing C. elegans, other “simple” organisms, 
and rodent models. However, human dis-
eases are far too complex and can therefore 
only be poorly mimicked in their entirety 
in rodents. Importantly, he indicated that 
the state of genetics, systems biology, and 
informatics – I would also add the various in 
vivo imaging techniques – enable biomedi-
cal scientists to study human diseases in a 
non-invasive fashion like never before in the 
new “model system” (man).
Using rodent models myself to study 
neuroinflammation and other pathologies 
following mild blast-induced  traumatic 
In 2007, the Faculty Senate at the Uniformed 
Services University (USU) in Bethesda, MD, 
USA, invited Dr. Sydney Brenner, one of 
the creative geniuses of modern genetics, 
to deliver the annual David Packard Lecture. 
“No powerpoint or any visual aid necessary; 
one good phrase is worth a thousand slides,” 
Dr. Brenner said before his presentation – 
and he was right. He delivered a brilliant 
talk entitled Humanities’ Genes. One of the 
main points of his lecture was that “the 
next model system is ourselves,” which 
could have been the subtitle. Dr. Brenner 
presented compelling arguments (using his 
own disease condition also as an example) 
of why in the twenty-first century biomedi-
cal scientists can (and should) switch from 
animal modeling of human diseases to 
studying the real subject: man. This may 
come as a surprise from one of the found-
ers of molecular biology. Dr. Brenner’s early 
work includes the discovery of messenger 
and transfer RNA, frameshift mutations, 
the triplet nature of the genetic code, and 
the creation of the first computer matrix 
analysis of nucleic acids.
In 1963, exactly 50 years ago, Dr. Brenner 
wrote to Dr. Max Perutz1: “it is now widely 
realized that nearly all the ‘classical’ prob-
lems of molecular biology have either been 
solved or will be solved in the next dec-
ade. Because of this, I have long felt that 
the future of molecular biology lies in the 
extension of research to other fields of biol-
ogy, notably development and the nervous 
system.” Then he described his vision for 
future studies: “we should like to attack the 
problem of cellular development in a simi-
lar fashion, choosing the simplest possible 
differentiated organism and subjecting 
it to the analytical methods of microbial 
genetics. Thus we want a  multicellular 
brain injury (TBI) (2), Dr. Brenner’s 
 message came to me as I was reading the 
paper “Genomic responses in mouse mod-
els poorly mimic human inflammatory 
disease” (3). The work by Seok, Warren, 
and Cuenca (and their 30 plus co-authors 
with contributions by the Inflammation 
and Host Response to Injury, Large Scale 
Collaborative Research Program) com-
pared the genomic (transcriptional) 
responses to burn, trauma, and endotox-
emia in humans and their respective mouse 
models. The authors have shown that the 
three different conditions trigger strik-
ingly similar inflammatory responses in 
humans (detected at the level of the tran-
scriptome) regardless of the etiology (i.e., 
burn, trauma, or endotoxemia). However, 
the transcriptional responses detected 
in the mouse models were strikingly dif-
ferent from their human counterparts. 
Moreover, the transcriptional responses 
among the three different mouse models 
were dissimilar.
The authors’ work also shows that the 
significantly regulated pathways in the 
human diseases are distinct from their 
respective murine models. Finally – and 
very importantly – the authors dem-
onstrated that the temporal pattern of 
changes (“gene response time” or “recov-
ery times to normal values”) in the 
human conditions were substantially dif-
ferent from their corresponding murine 
models. While gene response times were 
similar between rodents and humans 
(6–12 h) for all three conditions, recov-
ery times were on entirely different scales: 
weeks to months (even a year) in humans 
and less than 10 days in their respective 
murine models. For instance, recovery 
time for burns in mice was 7 days whereas 
in humans it was over one full year. While 
there are other potential explanations for 
the observed discrepancies (some of which 
Of timescales, animal models, and human disease: the 50th 
anniversary of C. elegans as a biological model
Denes V. Agoston*
Department of Anatomy, Physiology and Genetics, Uniformed Services University, Bethesda, MD, USA
*Correspondence: denes.agoston@usuhs.edu
Edited by:
Mattias K. Sköld, Uppsala University, Sweden
Keywords: disease models, animal, translational research, trauma, nervous system, inflammation, clinical studies
1http://elegans.som.vcu.edu/Sydney.html
www.frontiersin.org October 2013 | Volume 4 | Article 129 | 1
OpiniOn Article
published: 01 October 2013
doi: 10.3389/fneur.2013.00129
want to seriously consider Dr. Brenner’s 
advice: “the next (and maybe best) model 
system is ourselves.”
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potential approach to developing such 
a temporal conversion factor between 
some rodent models of induced human 
pathologies (e.g., burns, TBI) where the 
time of the insult is known. In the case of 
burns, obtaining biosamples from rodents 
within minutes after the insult, continuing 
to sample at a high temporal resolution 
for up to 7–10 days (the recovery time 
for rodents as indicated by the authors), 
and comparing all rodent samples to 
samples obtained from human patients 
at the same post-injury time points but 
collected for up to 1 year (the recovery 
time for humans) can identify similari-
ties (if any) between patterns of genomic 
inflammatory responses in the two differ-
ent organisms.
Establishing “conversion factor(s)” (or 
algorithm) between rodent and human 
time scales for inflammatory processes 
(among others) would be critical due to 
inflammation’s key role in various diseases 
including TBI. Given the lack of efficacious 
drugs for TBI (4), the field would benefit 
from (re)designing clinical trials using such 
evidence-based timescale for testing anti-
inflammatory treatments that have worked 
in rodents (e.g., minocycline). Such a con-
version factor/algorithm would also enable 
us to better compare outcomes between 
animal models and the clinical population 
in TBI (5).
In summary, we biomedical  scientists – 
especially those of us performing “trans-
lational” research – need to pay closer 
 attention to the differences between human 
and rodent timescales in order to draw 
more clinically useful conclusions from our 
experimental work. And whenever meth-
odologically and ethically possible, we may 
are  discussed online)2,3, these observations 
highlight a very critical yet almost com-
pletely neglected aspect of animal mod-
eling: the different timescales.
Biological processes run on vastly dif-
ferent timescales in humans compared to 
the various animal models used in bio-
medical research. After all, the fast life-
cycle of C. elegans (embryogenesis ∼12 h, 
development to the adult stage occurs in 
2.5 days, and the life span is 2–3 weeks) 
was one of the key features that the 
worm was selected as a model organ-
ism. Compare this with the gestational 
period in mice (19–21 days) and humans 
(∼266 days) – to focus on a relatively 
well-conserved, basic biological process 
between rodents and humans. Timescale 
differences in other fundamental biologi-
cal processes (e.g., sexual maturity, lifes-
pan, and metabolism) in rodents versus 
humans illustrate rather well that a “rat 
day” is not equivalent to a human day; 
and studies comparing the temporal pat-
terns of complex, molecular, and system 
level changes between the two species are 
limited. Consequently, we currently lack 
inter-species “conversion factor(s)” (or 
rather an algorithm) that would enable 
comparisons and adjustments between the 
temporal patterns of basic physiological 
processes as well as pathological mecha-
nisms (e.g., inflammation).
The approach taken by the authors of 
the PNAS paper (comparing rodent and 
human genomic responses) maybe one 
2http://www.pnas.org/content/early/2013/07/11/ 
1308333110.full.pdf + html
3http://www.pnas.org/content/early/2013/07/10/ 
1307452110.full.pdf?etoc
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